Table 1 Study sociodemographic and clinical characteristics.
All Patients (N = 933) | Arm A (N = 466) | Arm B (N = 467) | |
|---|---|---|---|
Age | |||
Mean ± SD | 64.1 ± 9.3 | 63.9 ± 9.6 | 64.3 ± 9.1 |
Median (Q1, Q3) | 65.0 (58.0, 71.0) | 64.0 (57.0, 71.0) | 65.0 (59.0, 71.0) |
Sex | |||
Male | 546 (58.5) | 271 (58.2) | 275 (58.9) |
Female | 387 (41.5) | 195 (41.8) | 192 (41.1) |
Race | |||
White | 769 (85.3) | 378 (83.8) | 391 (86.9) |
Black | 113 (12.5) | 62 (13.7) | 51 (11.3) |
Other | 19 (2.1) | 11 (2.4) | 8 (1.8) |
Missing/unknown | 32 | 15 | 17 |
Ethnicity | |||
Hispanic/Latino | 54 (5.9) | 28 (6.2) | 26 (5.7) |
Non-Hispanic | 858 (94.1) | 427 (93.8) | 431 (94.3) |
Missing/Unknown | 21 | 11 | 10 |
Disease stage (ISS Stage) | |||
I | 263 (31.6) | 127 (31.0) | 136 (32.1) |
II | 356 (42.8) | 175 (43.0) | 181 (42.7) |
III | 213 (25.6) | 106 (26.0) | 107 (25.2) |
Missing/unknown | 101 | 58 | 43 |
Genetic high riska | |||
Yes | 297 (33.6) | 147 (33.4) | 150 (33.9) |
No | 586 (66.4) | 293 (66.6) | 293 (66.1) |
Missing/unknown | 50 | 26 | 24 |
ECOG performance status | |||
0 | 379 (40.6) | 178 (38.2) | 201 (43.0) |
1 | 458 (49.1) | 237 (50.9) | 221 (47.3) |
2 | 82 (8.8) | 42 (9.0) | 40 (8.6) |
3 | 14 (1.5) | 9 (1.9) | 5 (1.1) |
Insurance | |||
Private/medicare & private | 624 (66.9) | 303 (65.0) | 321 (68.7) |
Medicare/other gov | 210 (22.5) | 102 (21.9) | 108 (23.1) |
Medicaid/uninsured | 71 (7.6) | 45 (9.7) | 26 (5.6) |
Other/unknown | 28 (3.0) | 16 (3.4) | 12 (2.6) |
Allostatic load score | |||
Mean ± SD | 3.0 ± 1.0 | 3.0 ± 1.0 | 3.0 ± 1.0 |
Median (Q1, Q3) | 2.0 (1.0, 3.0) | 2.0 (1.0, 3.0) | 2.0 (1.0, 3.0) |
nSES Index | |||
Mean ± SD | 54.2 ± 4.5 | 53.9 ± 4.5 | 54.5 ± 4.4 |
Median (Q1, Q3) | 53.7 (51.5, 56.8) | 53.3 (51.3, 56.5) | 54.1 (51.6, 57.1) |
Baseline GP4 | |||
Mean ± SD | 1.8 ± 1.4 | 1.8 ± 1.4 | 1.8 ± 1.4 |
N missing | 27 | 14 | 13 |
Baseline GP5 | |||
Mean ± SD | 0.3 ± 0.8 | 0.4 ± 0.8 | 0.3 ± 0.8 |
N missing | 74 | 39 | 35 |
Baseline HI7 | |||
Mean ± SD | 1.6 ± 1.3 | 1.6 ± 1.3 | 1.6 ± 1.3 |
N missing | 30 | 16 | 14 |
